These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 28471350)
1. Antiviral therapy reduces risk of haemorrhagic stroke in patients with HCV infection: a nationwide cohort study. Lin MS; Chung CM; Lin WY; Wei KL; Wang J; Lee YY; Hu JH; Tung TH; Lin YS Antivir Ther; 2018; 23(1):43-52. PubMed ID: 28471350 [TBL] [Abstract][Full Text] [Related]
2. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study. Lin MS; Chen TH; Lin WY; Liu CH; Hsieh YY; Chiu WN; Chang CH; Chen MY; Chung CM; Lin YS BMC Gastroenterol; 2017 Aug; 17(1):99. PubMed ID: 28814273 [TBL] [Abstract][Full Text] [Related]
3. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hsu YC; Lin JT; Ho HJ; Kao YH; Huang YT; Hsiao NW; Wu MS; Liu YY; Wu CY Hepatology; 2014 Apr; 59(4):1293-302. PubMed ID: 24122848 [TBL] [Abstract][Full Text] [Related]
4. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study. Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study. Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH Hepatology; 2016 Mar; 63(3):721-30. PubMed ID: 26662347 [TBL] [Abstract][Full Text] [Related]
6. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Hsu CS; Kao JH; Chao YC; Lin HH; Fan YC; Huang CJ; Tsai PS Aliment Pharmacol Ther; 2013 Aug; 38(4):415-23. PubMed ID: 23802888 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study. Cheng JS; Hu JH; Chang MY; Lin MS; Ku HP; Chien RN; Chang ML J Psychiatry Neurosci; 2021; 46(6):E583-E591. PubMed ID: 34728558 [TBL] [Abstract][Full Text] [Related]
8. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study. Lin SY; Lin CL; Ju SW; Wang IK; Lin CC; Lin CH; Hsu WH; Liang JA PLoS One; 2017; 12(3):e0173125. PubMed ID: 28264004 [TBL] [Abstract][Full Text] [Related]
9. Risk of New-Onset Atrial Fibrillation Among Asian Chronic Hepatitis C Virus Carriers: A Nationwide Population-Based Cohort Study. Yang YH; Chiang HJ; Yip HK; Chen KJ; Chiang JY; Lee MS; Sung PH J Am Heart Assoc; 2019 Nov; 8(22):e012914. PubMed ID: 31711382 [TBL] [Abstract][Full Text] [Related]
10. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection - A Nationwide Cohort Study. Lin MS; Chung CM; Chang ML; Chen MY; Chang ST; Chu PH; Chen TH; Lin WY; Huang TJ; Lin YS Circ J; 2018 May; 82(6):1623-1631. PubMed ID: 29503408 [TBL] [Abstract][Full Text] [Related]
11. Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan. Hsu YH; Hung PH; Muo CH; Tsai WC; Hsu CC; Kao CH Medicine (Baltimore); 2015 Nov; 94(47):e2113. PubMed ID: 26632730 [TBL] [Abstract][Full Text] [Related]
12. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Hsu YC; Ho HJ; Huang YT; Wang HH; Wu MS; Lin JT; Wu CY Gut; 2015 Mar; 64(3):495-503. PubMed ID: 25398770 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study. Hsu YH; Muo CH; Liu CY; Tsai WC; Hsu CC; Sung FC; Kao CH J Hepatol; 2015 Mar; 62(3):519-25. PubMed ID: 25263004 [TBL] [Abstract][Full Text] [Related]
14. Nephrotic Syndrome is Associated with Increased Risk of Ischemic Stroke. Huang JA; Lin CH; Chang YT; Lee CT; Wu MJ J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104322. PubMed ID: 31427188 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study. Tsai HH; Liou HH; Muo CH; Lee CZ; Yen RF; Kao CH Neurology; 2016 Mar; 86(9):840-6. PubMed ID: 26701382 [TBL] [Abstract][Full Text] [Related]
16. Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era. Alvaro-Meca A; Berenguer J; Díaz A; Micheloud D; Aldámiz-Echevarría T; Fanciulli C; Resino S PLoS One; 2017; 12(6):e0179493. PubMed ID: 28617855 [TBL] [Abstract][Full Text] [Related]
17. Association Between Alcoholic Cirrhosis and Hemorrhagic Stroke: A Nationwide Population-based Study. Lin SY; Lin CL; Chen WS; Lin CC; Lin CH; Hsu WH; Hsu CY; Kao CH Alcohol Alcohol; 2019 May; 54(3):302-309. PubMed ID: 30957143 [TBL] [Abstract][Full Text] [Related]
18. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons. Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386 [TBL] [Abstract][Full Text] [Related]
19. Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan. Yeh CC; Wu MM; Wu CM; Sung FC; Muo CH; Te A; Su FH Viruses; 2021 Apr; 13(5):. PubMed ID: 33925141 [TBL] [Abstract][Full Text] [Related]
20. Haemodialysis and the risk of stroke: A population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Kuo CC; Lee CT; Ho SC; Kuo HW; Wu TN; Yang CY Nephrology (Carlton); 2012 Mar; 17(3):243-8. PubMed ID: 22171843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]